ITGA2B and Glanzmann thrombasthenia 1: Given that often, the first bleeding symptoms of GT appear in childhood, screening for the pathogenic variants of the ITGA2B and ITGB3 genes is essential for genetic counselling and identification of those with a severe bleeding tendency that could potentially reduce the risk of PPH through appropriate preventative care [29].